Director/PDMR Shareholding
Updated : 07:11
EKF Diagnostics Holdings plc
("EKF", the "Company")
Director/PDMR Shareholding
EKF Diagnostics Holdings plc (AIM: EKF) announces that on 24 May 2019, the Company was notified by Adam Reynolds, Non-executive Director, that he has today sold 400,000 ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares").
EKF also announces that on the same date, it was notified by Christopher Mills, Non-executive Chairman, that he has today purchased 150,000 Ordinary Shares.
Following the above transactions, further details of which are provided below, Adam Reynolds is now interested in 1,668,613 Ordinary Shares, representing 0.37% of the Company's issued share capital and Christopher Mills is now interested in 136,113,591 Ordinary Shares in aggregate, representing 29.97% of the Company's issued share capital.
Christopher Mills is a partner and Chief Investment Officer of Harwood Capital LLP, which acts as an investment manager to Oryx International Growth Fund Limited ("Oryx") and as an investment adviser to the North Atlantic Smaller Companies Investment Trust PLC ("NASCIT"), an investment trust. Oryx (of which Mr. Mills is also a director and shareholder) holds 37,963,591 Ordinary Shares, NASCIT holds 98,000,000 Ordinary Shares and 150,000 Ordinary Shares are held directly by Mr. Mills.
EKF Diagnostics Holdings plc | |
Christopher Mills, Non-Executive Chairman | Tel: 029 2071 0570 |
Julian Baines, CEO | |
Richard Evans, FD & COO | |
N+1 Singer (Nomad & Broker) | Tel: 020 7496 3000 |
Aubrey Powell / Lauren Kettle / George Tzimas (Corporate Finance) Tom Salveson (Corporate Broking) | |
Walbrook PR Limited Tel: 020 7933 8780 or ekf@walbrookpr.com | |
Paul McManus/ Lianne Cawthorne | Mob: 07980 541 893 / 07584 391 303 |
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Adam Reynolds | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Non-executive Director
| ||||
b)
| Initial notification /Amendment
| Initial Notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| EKF Diagnostics Holdings plc | ||||
b)
| LEI
| 213800DXTF3EAUK1AR05 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary shares of 1p each ("Ordinary Shares")
ISIN Code: GB0031509804
| ||||
b)
| Nature of the transaction
| Sale of shares | ||||
c)
| Price(s) and volume(s)
|
| ||||
d)
| Aggregated information
- Aggregated volume
- Price
| n/a | ||||
e)
| Date of the transaction
| 24 May 2019 | ||||
f)
| Place of the transaction
| London Stock Exchange |
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Christopher Mills | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Non-executive Chairman
| ||||
b)
| Initial notification /Amendment
| Initial Notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| EKF Diagnostics Holdings plc | ||||
b)
| LEI
| 213800DXTF3EAUK1AR05 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary shares of 1p each ("Ordinary Shares")
ISIN Code: GB0031509804
| ||||
b)
| Nature of the transaction
| Purchase of shares | ||||
c)
| Price(s) and volume(s)
|
| ||||
d)
| Aggregated information
- Aggregated volume
- Price
| n/a | ||||
e)
| Date of the transaction
| 24 May 2019 | ||||
f)
| Place of the transaction
| London Stock Exchange |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.